Search
Location

Production sites


Leading production capacities around the globe.


Our FDA-approved Tippecanoe site in Lafayette, Indiana, USA offers the world’s largest capacity for HPAPI manufacturing, at 170 m³.

With a total of three HPAPI plants on site, we can produce up to six types of HPAPI simultaneously – even with operational exposure levels (OELs) as low as 0.1 µg/m³. This unique capacity means that we can scale production up or down in line with your specific needs – from major projects to laboratory quantities.

In addition to its HPAPI capacity, our Tippecanoe site also has extensive cryogenic capabilities, with reactors that support reactions down to -80 °C. The facility can also assist with tasks including analytical and physical characterization (e.g. x-rays, particle size, NMR, etc.), large-scale fermentation (with a capacity for secondary metabolites of 2,500 m³), solvent recovery, on-site incineration of solids and liquids, and the generation of purified water and steam.

Key Facts:
  • Location: Lafayette, Tippecanoe, Indiana, USA

  • Number of employees: 550

  • Number of plants: 5 (including 3 HPAPI plants)

  • Total API/HPAPI/intermediate capacity: 860 m³

  • Number of reactors: 140 (volumes ranging from 0.1 – 15.2 m³)

  • Number of centrifuges: 23

  • Number of dryers: 21

  • Total fermentation capacity for secondary metabolites: 2,500 m³

  • Approvals/certifications: FDA approved; certified to ISO 9001 and ISO 14001

A CONTRACT MANUFACTURING LEADER FOR API, HPAPI AND HIGH VALUE INTERMEDIATES

Take a look at our main site in the U.S. (Chicago area) from a bird’s eye-view to gain an impression of our capacities and capabilities for custom production of API, HPAPI and intermediates for the pharmaceutical industry.

Exclusive Synthesis
EXCLUSIVE SYNTHESIS BROCHURE

Find further information on our portfolio of API, HPAPI and intermediates custom manufacturing.

Download brochure
CUSTOM MANUFACTURING TECHNOLOGIES - OTHER MENU ITEMS:
Contact

Evonik Health Care